The other is a standardized symptom rating scale that assesses exactly where the patient stands on each of the many constellations of symptoms of anxiety, from fears to fidgeting to frequency of ...
Voyage is the first-ever Phase 3 study of lysergide D-tartrate (LSD) with the primary endpoint measuring the change from baseline in the Hamilton Anxiety Rating Scale (HAM-A) score at week 12 for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results